The investigator proposes to perform a Phase I study assessing safety, efficacy, and
biomarker response to the therapeutic interventions of Etanercept followed by mifepristone
for veterans with Gulf War Illness. The investigator will conduct and repeat the exercise
challenge before treatment and on therapy to assess the impact of the interventions on
homeostatic regulation and the dynamic model identified in prior studies.
Phase:
Phase 1
Details
Lead Sponsor:
South Florida Veterans Affairs Foundation for Research and Education
Collaborators:
Nova Southeastern University United States Department of Defense